Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS

Publication

Liver cancer

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1191214

Publication Year

2015

PubMed ID

26020033

Publication Title

Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS. Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma. Liver Cancer. 2015 Mar; 4(2):115-25.